Abstract: Systems for selecting candidates for labelling and use in training a convolutional neural network (CNN) are provided, the systems comprising: a memory device; and at least one hardware processor configured to: receive a plurality of input candidates, wherein each candidate includes a plurality of identically labelled patches; and for each of the plurality of candidates: determine a plurality of probabilities, each of the plurality of probabilities being a probability that a unique patch of the plurality of identically labelled patches of the candidate corresponds to a label using a pre-trained CNN; identify a subset of candidates of the plurality of input candidates, wherein the subset does not include all of the plurality of candidates, based on the determined probabilities; query an external source to label the subset of candidates to produce labelled candidates; and train the pre-trained CNN using the labelled candidates.

Abstract: A control system for conducting an election may include a voter client configured to be used by a voter to cast a vote for a candidate, a registrar server, and a moderator server. The moderator server may be configured to obscure the identity of the voter. The registrar server may be configured to randomly assign a ballot to the obscured voter. The registrar server may be configured to encrypt the ballot. The moderator server may be configured to transmit the encrypted ballot to the voter client. The voter client may be configured to decrypt the encrypted ballot to recover the ballot. The voter client, in response to the voter selecting a desired candidate, may be configured to generate a ballot associated with a vote. The voter client may be configured to encrypt the ballot using a public key of the registrar server and a public key of the moderator server.

Abstract: The presently disclosed invention relates to products and methods of treating cancer in a patient comprising administering to the patient a pharmaceutically therapeutic dose of a chemotherapeutic, or any pharmaceutically acceptable salt, solvate, or prodrug thereof, conjugated to a nanocarrier. According to a further embodiment, the chemotherapeutic has a primary (1°) amine (—NH2) group in within a pharmaceutical structure of the chemotherapeutic structure. According to a further embodiment, the chemotherapeutic is one of a platinum-based pharmaceutical and an Anthracycline family pharmaceutical. According to a further embodiment, the chemotherapeutic is one of gemcitabine, methotrexate, cisplatin, oxaliplatin, doxorubicin, daunorubicine, idarubicine, and epirubicine. According to a further embodiment, the chemotherapeutic is either attached to the nanocarrier by means that includes covalent bonds or is attached by means that does not included covalent bonds.

Abstract: An organic light emitting diode having a substrate, a first electrode, a hole transporting layer proximate the first electrode, a second electrode, an electron transporting layer proximate the second electrode, and an emissive layer between the hole transporting layer and the electron transporting layer. The emissive layer includes a square planar tetradentate platinum or palladium complex, and excimers formed by two or more of the complexes are aligned such that emitting dipoles of the excimers are substantially parallel to a surface of the substrate.

Abstract: The use of brain signals in controlling wheelchairs is a promising solution for many disabled individuals, specifically those who are suffering from motor neuron disease affecting the proper functioning of their motor units. Almost two decades since the first work, the applicability of EEG-driven wheelchairs is still limited to laboratory environments. In this work, a systematic review study has been conducted to identify the state-of-the-art and the different models adopted in the literature. Furthermore, a strong emphasis is devoted to introducing the challenges impeding a broad use of the technology as well as the latest research trends in each of those areas.

Abstract: A system with an analyzer device in fluid communication with a sample of a bodily fluid is configured to chemically or electrochemically convert at least a portion of ammonium (NH4+) contained within the bodily fluid into ammonia (NH3) and dispel the converted ammonia (NH3) into a gas sensing chamber. An ammonia (NH3) sensor located within the gas sensing chamber in conjunction with a processor can quantify an amount of ammonia (NH3) present in the gas sensing chamber in relation to the total ammonia of the bodily fluid.

Abstract: The present invention provides a compound having the structure: wherein R3, R4, R5, R6, and R7 are each independently, H, halogen, CN, —CF3, —OCF3, —NO2, alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycle, —OH, —OAc, —OR13, —COR13, —CH2OR13, —SH, —SR13, —SO2R13, —NH2, —NHR13, —NR14R15, —NHCOR12, or —CONR14R15; R9, R10, R11, and R12 are each independently, H, CN, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, —OAc, —COR13, —SH, —SR13, —SO2R13, —NH2, —NHR13, —NR14R15, —NHCOR12, or —CONR14R15; wherein each occurrence of R13 is independently alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R14 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R15 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein when R14 is methyl, R15 is not methyl; wherein at least one of R9, R10, R11, and R12 is not H; wherein at least one of R3, R4, R5, R6, and R7 is not H.

Abstract: Aspects of the present invention relate to a cuvette platform including a body having a base and at least one cuvette mounting surface positioned above and parallel to the base and comprising at least one of side retainers and corner retainers configured to retain a cuvette, at least one peripheral mounting surface extending upward from a first edge of the base forming a right angle with the base and configured to receive at least one peripheral, at least one flange extending outward from a second edge of the base forming a right angle with the base and comprising at least one mounting feature.

Abstract: Described herein is a magnetic dendrometer having a frame, a spring-tension mechanism, and a magnet for moving together with the spring-tension mechanism. A magnetic sensor is attached to the frame. The magnetic sensor senses the linear motion of the magnet. This linear motion translates to trackable fluctuations in magnetic field. The magnetic fluctuations are converted to electrical signals by the magnetic sensor. A spring is attached to a free-floating wishbone-style component. The free-floating wishbone-style component is couped to a slider which has an adjustable, single-contact point with a target (e.g., a vine, a branch, etc.). The frame is a stationary frame that carries the magnetic sensor. The frame connected via the spring to the wishbone/slider combination cooperates with each other for providing linear motion to extend or contract the spring in length directions. The length variations of the dendrometer spring are converted to linear motion of the magnet and then into electronic signals.

Abstract: A T-Cell receptor (TCR) specific embedding model uses a bidirectional long short-term memory (LSTM) to generate representations for TCR sequences and predict a “next token” in a TCR sequence. The embedding model can be trained in an unsupervised manner using a large collection of TCR sequences, and can be combined with downstream models to perform tasks, such as a TCR-epitope binding prediction model and a clustering algorithm. The embedding model demonstrates significant of prediction improvement when compared to existing models.

Abstract: A system provides the minimum number of sensors that will be needed to uniquely identify locations where anomalous behavior is sensed that can be deployed within the specified budget. The system applies an Integer Linear Programming formulation and a Maximum Set-Group Cover (MSGC) formulation. One implementation of the system is applied to detect contaminants in a water distribution system.

Abstract: A communications device including an array of optical transmitters, each element of the array including an optical source and an antenna coupled to the optical source. The communications device also includes a plurality of tunable delay components interconnecting transmitters in the array of optical transmitters, and a communications signal path configured to conduct a communications signal through the array of the optical transmitters. The optical sources are synchronized.

Abstract: The presently disclosed subject matter relates generally to a highly ionically conductive solid electrolyte membrane and to batteries comprising such solid electrolyte membrane.

Abstract: Chimeric antigen receptors (CARs) including an scFv binding to coronavirus spike protein (S309 scFv), nucleic acids encoding the CARs, vectors including nucleic acids encoding the CARs, and cells expressing the CARs are provided. Methods of treating a subject with coronavirus are also provided, including administering to the subject a modified immune cell expressing a disclosed CAR.

Abstract: A modified bitumen includes bitumen and a bitumen modifier. The bitumen modifier includes composite particles. The composite particles include aluminosilicate nanostructures defining nanopores and micropores and paraffin wax adhered to surfaces of the aluminosilicate nanostructures. Modifying bitumen includes combining bitumen and the bitumen modifier.

Abstract: A system may include a meta-surface including multiple unit cells arranged along the meta-surface. Structural parameters of each unit cell may vary along the meta-surface. The system may further include at least a first active feed unit directed toward the meta-surface to generate a first beam. The first active feed unit may be configured to move relative to the meta-surface parallel to a 2-dimensional plane. The first beam is steerable by moving the first active feed unit.

Abstract: Compositions and methods relating to bacterial ribosomes selected to increase the incorporation of at least one glycosylated amino acid into a protein versus a wild-type bacterial ribosome. Selection embodiments include growing bacteria in the presence of a puromycin derivative, wherein a surviving clone has a ribosome that incorporates at least one glycosylated amino acid into a protein.

Abstract: The present relates to novel bioactive amphiphilic kanamycin compounds having the general formula of: where R may be a C4 to C20 branched or straight chained alkyl group or a substituted or unsubstituted aryl group. Also provided are methods of synthesizing and methods of using the compounds of the present invention. The compounds of the present invention are useful in treating and preventing various fungal and bacterial diseases.

Abstract: A facial mask having pathogen inactivation capabilities is disclosed. One embodiment comprises a mask and a pathogen inactivation system coupled to the mask. The pathogen inactivation system is configured to heat and inactivate bacteria and viruses.

Abstract: The disclosure relates to methods for separating mixtures of polyols, in particular mixtures of two of more different vicinal diols having close boiling points, thus making them difficult or impossible to separate using conventional distillation techniques. The polyol mixture is reacted with an aldehyde or ketone acetalization agent to form one or more acetals as corresponding acetalization reaction products. The acetalization reaction products are more easily separable either from each other (such as via distillation) or from an unreacted vicinal diol (such as via extraction, settling, or other phase separation). After separation, hydrolysis is performed on the acetalization reaction products to recover the vicinal diols as separate, purified components. The methods provide cost-effective processes for separating different polyols originally formed in admixture.